With advancements in early diagnosis, newborn screening, modern medical technology, and the extensive use of CFTR modulators, the median life expectancy of people with CF in the developed world has surpassed 40 years of age (McBennett et al., 2021; Elborn, 2016). Here, CFTR is linked to cystic fibrosis.